RD
Insider
Richard R. DeLuca
EVP&Pres, Merck Animal HeallthRichard R. DeLuca (EVP&Pres, Merck Animal Heallth) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Merck & Co., Inc. (MRK). The largest single filing was $5.9M of MRK (44,720 sh across 4 lots, as filed), executed Aug 10.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$11.2M
shares × price, as filed
Last traded
Aug 12
Filed Aug 12
Median ADV $1.4B across their filed names
Open performance→Volume by month
Buys $0
Sells $11.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
MRKRecent filings
MRKSALE
Merck & Co., Inc.
View filing →
$5.9M44,720 sh across 4 lots
Exec Aug 10
Filed Aug 12 · 4:10 PM ET MRKSALE Merck & Co., Inc. View filing → $749K
5,750 sh across 2 lots
Exec Aug 6
Filed Aug 10 · 4:28 PM ET MRKSALE Merck & Co., Inc. View filing → $4.6M
37,685 sh × $120.92
Exec Feb 6
Filed Feb 6 · 5:30 PM ET